Nephrol Dial Transplant (2000) 15: 1120-1123
© 2000 European Renal Association-European Dialysis and Transplant Association
Editorial Comments
Peritoneal solute transportwe know it is important, but what is it?
Department of Nephrology, North Staffordshire Hospital, Stoke-on-Trent and School of Postgraduate Medicine, Keele University, UK
The problem
The rate at which small molecules cross the peritoneal membrane is now established as one of the more important characteristics of patients treated by peritoneal dialysis. A number of prospective studies have demonstrated that high solute transport is associated with less satisfactory clinical outcome, including increased technical failure and reduced patient survival [17]. This prediction of outcome is independent of other established factors, such as residual renal function, co-morbidity (including diabetic status), body size and plasma albumin. The mechanism of this influence is probably multifactorial, although it has been known for some time that high solute transport is a common causative factor in ultrafiltration failure. This is due to the rapid rate of glucose absorption resulting in the loss of osmotic gradient early in the dialysis cycle [8,9]. Furthermore, solute transport is the one characteristic of peritoneal membrane function that has been
Measuring solute transport
Describing solute transport
Peritoneal surface area in contact with fluid
Diffusive mass transport through the capillary wall
Diffusive transport through the interstitium
Conclusion
Acknowledgments
Notes
References
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E. Goffin and O. Devuyst Phenotype and genotype: perspectives for peritoneal dialysis patients Nephrol. Dial. Transplant., November 1, 2006; 21(11): 3018 - 3022. [Full Text] [PDF] |
||||
![]() |
G. Gillerot, H. Debaix, and O. Devuyst Genotyping: a new application for the spent dialysate in peritoneal dialysis Nephrol. Dial. Transplant., May 1, 2004; 19(5): 1298 - 1301. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Paniagua, D. Amato, E. Vonesh, R. Correa-Rotter, A. Ramos, J. Moran, and S. Mujais Effects of Increased Peritoneal Clearances on Mortality Rates in Peritoneal Dialysis: ADEMEX, a Prospective, Randomized, Controlled Trial J. Am. Soc. Nephrol., May 1, 2002; 13(5): 1307 - 1320. [Abstract] [Full Text] [PDF] |
||||

